Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
avibactam
Description:
A beta-lactamase inhibitor used with certain antibiotics to help treat infections caused by resistant bacteria.
Primary topic:
Antibiotic Resistance in Bacteria (63%)
Related topics:
Antibiotic Resistance in Bacteria (63%),
Antibiotics Pharmacokinetics and Efficacy (7%)
Wikidata ID:
wiki/Q15410251
OpenAlex ID:
keywords/avibactam
Interplay between β-lactamases and new β-lactamase inhibitors
2019
·
Karen Bush
, Patricia A. Bradford
·
Nature Reviews Microbiology
·
626
Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor
2012
·
David E. Ehmann
, Haris Jahić
, et al.
·
Proceedings of the National Academy of Sciences
·
624
PDF
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
2013
·
George G. Zhanel
, Christopher D. Lawson
, et al.
·
Drugs
·
495
The rapid spread of carbapenem-resistant Enterobacteriaceae
2016
·
Robert F. Potter
, Alaric W. D’Souza
, et al.
·
Drug Resistance Updates
·
453
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
2013
·
David E. Ehmann
, Haris Jahić
, et al.
·
Journal of Biological Chemistry
·
406
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
2013
·
Sarah M. Drawz
, Krisztina M. Papp-Wallace
, et al.
·
Antimicrobial Agents and Chemotherapy
·
332
PDF
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
2015
·
Romney M. Humphries
, Shangxin Yang
, et al.
·
Antimicrobial Agents and Chemotherapy
·
279
Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
2013
·
Sushmita D. Lahiri
, Stefano Mangani
, et al.
·
Antimicrobial Agents and Chemotherapy
·
261
PDF
Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in bla KPC-2 -Harboring Klebsiella pneumoniae Sequence Type 307 Isolates
2017
·
Marla J. Giddins
, Nenad Macesic
, et al.
·
Antimicrobial Agents and Chemotherapy
·
242
The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases
2021
·
Carola Mauri
, Alberto Enrico Maraolo
, et al.
·
Antibiotics
·
239
PDF
Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance
2014
·
S. D. Lahiri
, M. R. Johnstone
, et al.
·
Antimicrobial Agents and Chemotherapy
·
225
PDF
In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015
2017
·
James A. Karlowsky
, Krystyna M. Kazmierczak
, et al.
·
Antimicrobial Agents and Chemotherapy
·
219
A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens
2015
·
Karen Bush
·
International Journal of Antimicrobial Agents
·
215
Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections
2014
·
Philippe Lagacé-Wiens
, Andrew Walkty
, et al.
·
Core evidence
·
207
PDF
β-Lactamase inhibition by avibactam in Mycobacterium abscessus
2014
·
Vincent Dubée
, Audrey Bernut
, et al.
·
Journal of Antimicrobial Chemotherapy
·
180
β-lactam/β-lactamase inhibitor combinations: an update
2018
·
Kamaleddin H. M. E. Tehrani
, Nathaniel I. Martin
·
MedChemComm
·
175
β-Lactam/β-Lactamase Inhibitor Combinations: From Then to Now
2014
·
Kimberly A. Toussaint
, Jason C. Gallagher
·
Annals of Pharmacotherapy
·
172
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy
2017
·
Darren Wong
, David van Duin
·
Drugs
·
163
Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms
2017
·
Domenico Schillaci
, Virginia Spanò
, et al.
·
Journal of Medicinal Chemistry
·
157
New β‐lactam–β‐lactamase inhibitor combinations in clinical development
2013
·
David M. Shlaes
·
Annals of the New York Academy of Sciences
·
148
In Vitro Activity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
2015
·
Douglas J. Biedenbach
, Krystyna Kazmierczak
, et al.
·
Antimicrobial Agents and Chemotherapy
·
146
The Road to Avibactam: The First Clinically Useful Non-β-Lactam Working Somewhat Like a β-Lactam
2016
·
David Yuxin Wang
, Martine I Abboud
, et al.
·
Future Medicinal Chemistry
·
143
PDF
New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams
2020
·
Juan C. Vázquez-Ucha
, Jorge Arca-Suárez
, et al.
·
International Journal of Molecular Sciences
·
142
PDF
Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii
2021
·
Laurent Poirel
, Mustafa Sadek
, et al.
·
Antimicrobial Agents and Chemotherapy
·
139
In Vitro Susceptibility of Characterized β-Lactamase-Producing Strains Tested with Avibactam Combinations
2014
·
Henry Li
, Mark Estabrook
, et al.
·
Antimicrobial Agents and Chemotherapy
·
137
Show more works
View as search
Works count:
860
Citation count:
16,580
Year
Topic
Type